A new, high-performance brain-computer interface (BCI) can be rapidly implanted through a minimally invasive procedure. The new BCI solution has been implanted in over 50 patients.

Funding will advance commercialization of the Stentrode™ BCI platform and expand AI and engineering operations in New York and San Diego Synchron, a leader in non-surgical brain-computer interface ...

Neurosurgeon and Engineer Dr. Ben Rapoport, co-founder of Precision Neuroscience, joins WIRED to answer the internet's burning questions about the emerging technology of brain implants and ...

BOSTON--(BUSINESS WIRE)--Neurable Inc., the neurotechnology company democratizing BCI technology, announced today that it has raised an additional $13 million in funding from Ultratech Capital ...

Naqi’s planned acquisition of Wisear accelerates Naqi’s efforts towards commercialization and to establish a global standard for non-invasive neural interfaces. This acquisition marks a defining ...

Neurable, the leader in noninvasive brain-computer interface (BCI) technology designed for everyday life, today announced it has closed a $35 million Series A round to accelerate the commercialization ...